Vincaleukoblastine
10mM in DMSO
- Product Code: 245275
CAS:
2468-21-5
| Molecular Weight: | 336.43 g./mol | Molecular Formula: | C₂₁H₂₄N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used primarily in chemotherapy for treating various cancers, particularly Hodgkin's lymphoma and non-Hodgkin's lymphoma. It is also effective in managing advanced testicular cancer and some forms of leukemia. The compound works by inhibiting cell division through disruption of microtubule formation in mitotic spindles, leading to cancer cell death. Due to its potency, it is administered under strict medical supervision, often as part of combination therapy regimens. Its use may be limited by side effects such as neurotoxicity and bone marrow suppression.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | £67.52 |
+
-
|
Vincaleukoblastine
Used primarily in chemotherapy for treating various cancers, particularly Hodgkin's lymphoma and non-Hodgkin's lymphoma. It is also effective in managing advanced testicular cancer and some forms of leukemia. The compound works by inhibiting cell division through disruption of microtubule formation in mitotic spindles, leading to cancer cell death. Due to its potency, it is administered under strict medical supervision, often as part of combination therapy regimens. Its use may be limited by side effects such as neurotoxicity and bone marrow suppression.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
£0.00
£0.00
Total :